Sunshine Biopharma Inc. Disposal Group, Including Discontinued Operation, Other Expense
Sunshine Biopharma Inc. (SBFM) reported Disposal Group, Including Discontinued Operation, Other Expense of $0 for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense · last filed 2020-11-12
- Sunshine Biopharma Inc. disposal group, including discontinued operation, other expense for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, other expense for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, other expense for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, other expense for the quarter ending 2019-09-30 was $3.52K, a 7.25% decline year-over-year.
| Period end | Disposal Group, Including Discontinued Operation, Other Expense 3 month | Disposal Group, Including Discontinued Operation, Other Expense 3 month as first filed | Disposal Group, Including Discontinued Operation, Other Expense 6 month | Disposal Group, Including Discontinued Operation, Other Expense 9 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $0.00 10-Q/A · filed 2020-08-31 | $0.00 10-Q/A · filed 2020-08-31 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-18 | |||
| 2019-09-30 | $3.52K 10-Q · filed 2020-11-12 | $0.00 10-Q · filed 2019-11-13 | $7.04K derived: sum of 2 quarters · filed 2020-11-12 | $3.52K 10-Q · filed 2020-11-12 |
| 2019-06-30 | $3.52K 10-Q/A · filed 2020-08-31 | $0.00 10-Q · filed 2019-08-15 | $3.52K 10-Q/A · filed 2020-08-31 | |
| 2019-03-31 | $3.52K 10-Q · filed 2020-05-18 | |||
| 2018-09-30 | $3.79K 10-Q · filed 2019-11-13 | $7.94K derived: sum of 2 quarters · filed 2019-11-13 | $12.02K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $4.15K 10-Q · filed 2019-08-15 | $8.23K 10-Q · filed 2019-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |